Chelsea Baker, PA-C
Sr. Instructor, Medicine-Endocrinology/Metabolism/Diabetes

Publications

• Baker C, Retzik-Stahr C, Singh V, Plomondon R, Anderson V, Rasouli N. Should metformin remain the first-line therapy for treatment of type 2 diabetes?. Ther Adv Endocrinol Metab. 2021;12:2042018820980225. PubMed PMID: 33489086
• Petri M, Singh I, Baker C, Underkofler C, Rasouli N. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists. J Diabetes Complications. 2021 Feb;35(2):107733. PubMed PMID: 32948398
• Petri M, Singh I, Baker C, Underkofler C, Rasouli N. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists. J Diabetes Complications. 2020 Sep 6;:107733. [Epub ahead of print] PubMed PMID: 32948398
• Mather KJ, Bebu I, Baker C, Cohen RM, Crandall JP, DeSouza C, Green JB, Kirkman MS, Krause-Steinrauf H, Larkin M, Pettus J, Seaquist ER, Soliman EZ, Schroeder EB, Wexler DJ, Pop-Busui R. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020 Jul;165:108235. PubMed PMID: 32450102
• Yusra Azhar, MBBS, Chelsea A Baker, MS, PA-C and Neda Rasouli. Diabetes of Unknown Cause. In: Draznin, B. Atypical diabetes: Pathophysiology, Clinical Presentations, and Treatment Options. American Diabetes Association; 2018.
• Daniel A. Kelmenson, MD, Kelsey Burr, MD, Yusra Azhar, MBBS, Paul Reynolds, PharmD, BCPS, Chelsea A. Baker, MS, MPAS, and Neda Rasouli, MD. Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin. J Investig Med High Impact Case Rep. 2017, 5(2). https://doi.org/10.1177/2324709617712736